Tough calls in transplant case
December 22nd, 2007Definition of experimental procedures is murky issue
From Los Angeles Times:
The parents of a seventeen-year-old leukemia patient are blaming their insurance company, Cigna HealthCare, for their daughter’s death after Cigna declined to pay for a liver transplant. The company later reversed itself but word of the decision came too late to save Nataline Sarkisyan, who had been in intensive care at UCLA Medical Center for complications following a successful bone marrow transplant.
The case highlights tensions among physicians, patients and insurers over the definition of experimental procedures.


